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Background: Fatigue is a common side effect of chemo-
therapy, but is poorly studied in pediatric HSCT recipients.
Hope, or goal-directedness, may be impacted by fatigue. The
incidence and severity of fatigue and its impact on hope
warrants investigation.
Patients and Methods: Patients were eligible for enrollment
in this prospective study if they were between the ages of 5-
18 years. Patients unable to read English or otherwise unable
to complete the survey were ineligible. Subjects completed
the PedsQL Multidimensional Fatigue Scales(Fatigue QOL) and
Children’s Hope Scale. Subjects were enrolled during a regular
follow-up clinic visit and completed the survey. The results of
the fatigue surveys were then compared to healthy subjects
and oncology patients in a validated sample as reported by
Varni et al (Cancer, 2002; 94:2090-2106).
Results: Atotal of 25 subjectswhohadHSCTwere enrolled, at a
mean of 12 yrs. (range of 6-19 yrs). 2 had received autologous
HSCT, 23 had received allogeneic HSCT, and 1 patient received
an auto followed by an allo HSCT. 6 had GVHD at the time of
surveycompletion.HSCTrecipientshadanaverageTotal Fatigue
QOL score of 69.9 (range 38.9-95.8) and18/25 (72%) had a lower
score than the average for healthy subjects. HSCT recipients had
a statistically signiﬁcant lower average Total Fatigue QOL score
(69.9 vs. 80.5, p¼0.002) and average General Fatigue QOL score
(71.3 vs. 85.3, p¼0.002), and a trend to a lower average Sleep
FatigueQOL score (62.65vs. 75, p¼0.002),whencomparedwith
healthysubjects. Therewasnostatistically signiﬁcantdifference
in average Cognitive Fatigue QOL scores (73.98 vs. 81.14,
p¼0.63).There was no statistically signiﬁcant differences in
average FatigueQOL scores in SCTrecipientswhen compared to
patients undergoing chemotherapy. Proxy reports of fatigue
were higher than comparative populations. An analysis of fac-
tors failed to show any signiﬁcant impact on fatigue including
age, days post transplant, sex, TBI received, GVHD, mental
illness, ICU admission, and malnutrition-impacted fatigue or
hope. The average hope scorewas 0.76 (range of 0.46-1), which
corresponds to feeling hopeful “a lot of the time.” There was a
direct correlationbetweenTotal FatigueQOLandhopescores (r-
0.472, p¼0.02).
Conclusions: Fatigue is more prominent in pediatric HSCT
recipients than a control population. Fatigue is related to
hope. Fatigue experienced by HSCT recipients was similar to
that seen in children receiving chemotherapy. Proxy reports
of fatigueweremuch greater than those reported by both the
subject and compared to healthy and oncology proxy reports.
Larger prospective studies are needed to determine risk
factors for fatigue and to develop interventions to alleviate
fatigue in pediatric HSCT recipients.231
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Background: Children’s experience of stem cell trans-
plantation (SCT) is often marked with psychological distress
and poor quality of life. While coping with the exigencies of
life-threatening illness and treatment, children must also
deal with being conﬁned to a hospital isolation room for one
to several months.We hypothesized that there are numerous
evident stressors associated with being conﬁned to an
isolation roomwhile undergoing SCT that may contribute to
heightened anxiety and general psychological distress.
Methods: We aimed to identify stressors of pediatric SCT
isolation by interviewing members of a multidisciplinary pe-
diatric SCT care team. 33 participants represented all profes-
sional roles within the team, including physicians, nurses,
psychologists, social workers, child life specialists, chaplains,
school teachers, dieticians, occupational therapists, house-
keepers and clinical researchers. 20 semi-structured interviews
of 30-60 minutes each were conducted with members of the
same profession. The 11 interview questions pertained to the
isolation room, daily life in isolation, and distressing moments,
among others topics. Four researchers then performed an
inductive thematic analysis, developing a list of 13 codes, indi-
vidually coding interview excerpts, analyzing code application
frequencies and co-occurrences across professional groups, and
summarizing ﬁndings into themes.
Results: 4 main themes were identiﬁed: Lack of Control Over
their Life in the Hospital, Missing Out on the Rest of theWorld,
Changes in Social Relationships, and Disengagement from
Daily Life Activities. The most frequently applied codes were
also those with the highest co-occurrenceeConnectedness,
Family Involvement, Social Interaction, Control andMotivation.
Conclusion: From the collective perspective of a particular
pediatric SCT care team, children experience numerous
interrelated stressors associated with physical isolation
during SCT, as indicated by the 13 identiﬁed codes, and their
frequencies and co-occurrences across professional groups.
The four presented overarching themes can be targeted in
efforts to minimize patient anxiety and psychological
distress, potentially contributing to improved quality of life
and emotional well-being during hospitalization. To achieve
a more comprehensive understanding of patients’ emotional
needs from their clinical environments, this study must be
supplemented by patient and family perspectives of their
emotional experiences in isolation for SCT.232
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Background: Improved survival after allogeneic hematopoi-
etic cell transplantation (allo-HCT) enables us to learn more
about potential late complications after HCT, including meta-
bolic syndrome (MS). This is the ﬁrst study investigating the
prevalence or development of metabolic syndrome within the
ﬁrst year post-HCT in adultmyeloablative transplant recipients.
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prevalence of and risk factors associated with metabolic
syndrome early post-HCT in 785 human subjects. As data
was collected retrospectively, it required substitution for
certain metabolic syndrome parameters. Thus, we evaluated
metabolic characteristics using available objective data
referred to as modiﬁed metabolic syndrome (MMS).
Results: We demonstrated that the incidence of MMS was
34% pre-HCT, 48% at day 80 post-HCT, and 40% at one year
post-HCT. MMS at day 80 post-HCT was predictive of having
MMS at one year post-HCT. Hypertriglyceridemia was the
predominant qualifying criteria for MMS, present in 91-93%
of patients. Age (>50) and TBI-based conditioning regimen
were signiﬁcantly associated with developing MMS at day 80
post-HCT (p¼0.0006 and p¼0.005, respectively). Both TBI
and age remain highly signiﬁcant in multivariate analysis
(p¼0.0009 for TBI and p¼0.0001 for age) at day 80 post-HCT.
TBI was also predictive of MMS at 1 year post-HCT (p¼0.01).
Conclusion: Although we substitute a number of the meta-
bolic syndrome factors based on data availability, we believe
that the substituted factors used in this study are still clini-
cally relevant as risk factors for coronary heart disease. These
results support the need for nutrition and lifestyle interven-
tion in order to prevent and treat metabolic abnormalities
among patients who survive the acute transplant period.Figure 1. Provider population.
Figure 2. Barriers to oncofertility education practice experienced by hema-
tology oncology physicians and nurses.233
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Background: Infertility frequently occurs in long-term sur-
vivors of hematopoietic stem cell transplant (HSCT). By the
timepatients are referred forHSCT, theyhaveoftenundergone
cancer treatments that cause infertility. The burden of early
education fallson thehematologyoncology teamthat cares for
the patient upon initial cancer diagnosis. Comprehensive
oncofertility education should include two areas: the risk of
cancer treatment on future fertility and fertility preservation
(FP) options. This study sought to characterize the education
practice and attitudes of hematology oncology physicians and
nurses towardsoncofertilityeducation inpatientswhomaybe
HSCTeligible and to determine patients’ interest in education.
Methods: A multidisciplinary team developed 3 surveys to
evaluate patients, nurses, and physicians using published
literature and unique questions targeting our population.
The University of Virginia’s Institutional Review Board (IRB)
authorized the surveys as IRB exempt. Practicing hematology
oncology nurses and physicians were eligible. Potential HSCT
eligible patients diagnosed with lymphoma, leukemia, or
myeloma in the last 2 years and were either women ages 18-
45 or men ages 18-60 at time of diagnosis were eligible.
Results: A total of 23 hematologic cancer patients ages 23-49
completed the survey as well as 43 providers (Figure 1).
Education on the risk of cancer treatment on future fertility
was received by 52% of patients, and only 26% of patients
received FP options. 81% of women and 31% of men wereinterested in discussing their fertility, learning about FP
options, or a fertility referral and counseling service. Of those
interested, 67% received education on the risk of cancer
treatment to fertility and 42% received FP education. Of
interested patients who received education, 63% were
satisﬁed with risk of cancer treatment education, and 80%
were satisﬁed with FP education. Of the surveyed providers,
75% of nurses and 33% of physicians did not feel comfortable
discussing FP options with patients and 89% of nurses and
86% of physicians felt they needed more information on FP
options. Physicians indicated patients’ illness and nurses
indicated their own knowledge of FP as the greatest barriers
to education (Figure 2).
Conclusions: The majority of hematology oncology patient
participants did not receive comprehensive oncofertility edu-
cation. Unfortunately, many patients interested in education
did not receive it. Providers need oncofertility education to
improve their ability to address topics. HSCT programs should
collaborate with local fertility specialists to educate primary
